These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 3806987)
21. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia. Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214 [TBL] [Abstract][Full Text] [Related]
22. Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature. Vasef MA; Murata-Collins JL; Alsabeh R; Medeiros LJ Arch Pathol Lab Med; 1998 Jan; 122(1):77-83. PubMed ID: 9448022 [TBL] [Abstract][Full Text] [Related]
23. Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings. Rigolin GM; Porta MD; Bugli AM; Castagnari B; Mauro E; Bragotti LZ; Ciccone M; Cuneo A; Castoldi G Eur J Haematol; 2004 Nov; 73(5):351-8. PubMed ID: 15458514 [TBL] [Abstract][Full Text] [Related]
24. Measuring the prognostic impact of ferritin levels in myelodysplastic syndrome patients: the role of susceptibility biases. Jerez A; Fernández A; Osma MM; Roldán V; Ortuño FJ; Vicente V Leukemia; 2010 Mar; 24(3):640-2. PubMed ID: 19890376 [No Abstract] [Full Text] [Related]
25. Red cell folate in elderly patients with myelodysplastic syndrome. Cafolla A; Dragoni F; Girelli G; Tosti ME; Monarca B; Kendall R; Scott CS Eur J Haematol; 1998 Sep; 61(3):160-3. PubMed ID: 9753411 [TBL] [Abstract][Full Text] [Related]
26. Abnormalities of cytoskeletal proteins of the red blood cells in myelodysplastic syndromes. de Cataldo F; Cairoli R; Baudo F; Pezzetti L; Lo Cunsolo CL; Perutelli P; Mori PG Int J Hematol; 1994 Apr; 59(3):227-9. PubMed ID: 8011992 [No Abstract] [Full Text] [Related]
27. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia. Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470 [TBL] [Abstract][Full Text] [Related]
28. Quantitative and qualitative studies of red cell ferritin in refractory anemia of myelodysplastic syndrome. Ohhara Y Eur J Haematol; 1993 Jul; 51(1):31-7. PubMed ID: 8348942 [TBL] [Abstract][Full Text] [Related]
29. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935 [TBL] [Abstract][Full Text] [Related]
30. [Auto- and alloreactivity of T lymphocytes in myelodysplastic syndrome]. Cukrová V; Neuwirtová R; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I Cas Lek Cesk; 2006; 145(8):647-52; discussion 653. PubMed ID: 16995421 [TBL] [Abstract][Full Text] [Related]
31. Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis. Elghetany MT; Hudnall SD; Gardner FH Haematologica; 1997; 82(1):21-4. PubMed ID: 9107077 [TBL] [Abstract][Full Text] [Related]
32. [Immunosuppressive therapy for low-risk MDS: markers for good response]. Chuhjo T Rinsho Ketsueki; 2004 Apr; 45(4):274-80. PubMed ID: 15168442 [No Abstract] [Full Text] [Related]
34. [Refractory anemia and preleukemia: an analysis of 92 cases]. Xu K; Hao Y Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):65-8. PubMed ID: 11601200 [TBL] [Abstract][Full Text] [Related]
35. [Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)]. Kitamura K; Asano S; Mizoguchi H; Takaku F Rinsho Ketsueki; 1993 Dec; 34(12):1540-9. PubMed ID: 8295327 [TBL] [Abstract][Full Text] [Related]
36. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome]. Sarycheva TG; Tsvetaeva NV; Kozinets GI Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781 [TBL] [Abstract][Full Text] [Related]
37. In myelodysplastic syndrome cases, what should be the level of ferritin which has prognostic value? Senturk Yikilmaz A; Akinci S; Bakanay ŞM; Dilek I Transfus Clin Biol; 2019 Nov; 26(4):217-223. PubMed ID: 31420221 [TBL] [Abstract][Full Text] [Related]
38. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes. Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130 [TBL] [Abstract][Full Text] [Related]
39. Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. Ghoti H; Amer J; Winder A; Rachmilewitz E; Fibach E Eur J Haematol; 2007 Dec; 79(6):463-7. PubMed ID: 17976187 [TBL] [Abstract][Full Text] [Related]
40. [Immunohematologic study in 112 patients with myelodysplastic syndromes: 10-year analysis]. Arriaga F; Bonanad S; Larrea L; de la Rubia J; López F; Sanz MA; Sanz G; Marty ML Sangre (Barc); 1995 Jun; 40(3):177-80. PubMed ID: 7570268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]